A FODMAP Diet for Pain in Women With Endometriosis and Gut Symptoms
Tests a FODMAP diet for pain in women with endometriosis and bowel symptoms.
Plain-language title generated from the registry record
Registry title: Effect of FODMAP Diet on Pain, Quality of Life, and Sexual Function in Women With Pelvic Endometriosis and Gastrointestinal Symptoms
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT07590895, who can take part
Where in Italy
- Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Trial code
- NCT07590895
- Record updated
- 15 May 2026
- Original description
The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control groupRead full original descriptionShow less
Effect of FODMAP Diet on Pain, Quality of Life, and Sexual Function in Women With Pelvic Endometriosis and Gastrointestinal Symptoms: a Randomized Controlled Trial
The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control group
Inclusion: Age between 18 and 45 years; BMI between 18.5 and 24.9,; Surgical, clinical or instrumental diagnosis of endometriosis; Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin or progestin treatment or in the absence of hormonal treatment.
Exclusion: Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes); chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis); women with metabolic diseases that require specific dietary indications such as in the case of diabetes and celiac disease; patients with obstructive uropathy, subocclusive intestinal stenosis; complex adnexal masses or typical endometriomas greater than 5 cm in diameter; women who are obese (BMI ≥ 30) or underweight (BMI < 18); women on vegetarian-vegan dietary regimens,.